1. Home
  2. NSP vs ANIP Comparison

NSP vs ANIP Comparison

Compare NSP & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insperity Inc.

NSP

Insperity Inc.

HOLD

Current Price

$38.55

Market Cap

1.7B

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$80.23

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSP
ANIP
Founded
1986
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
NSP
ANIP
Price
$38.55
$80.23
Analyst Decision
Hold
Strong Buy
Analyst Count
3
7
Target Price
$47.67
$102.14
AVG Volume (30 Days)
910.8K
403.3K
Earning Date
11-03-2025
11-07-2025
Dividend Yield
6.24%
N/A
EPS Growth
N/A
N/A
EPS
0.45
1.67
Revenue
$6,757,000,000.00
$826,880,000.00
Revenue This Year
$4.71
$43.41
Revenue Next Year
$6.40
$9.66
P/E Ratio
$85.99
$48.00
Revenue Growth
3.19
48.87
52 Week Low
$31.00
$52.50
52 Week High
$95.98
$99.50

Technical Indicators

Market Signals
Indicator
NSP
ANIP
Relative Strength Index (RSI) 57.67 34.84
Support Level $34.14 $80.30
Resistance Level $36.32 $83.60
Average True Range (ATR) 1.32 2.33
MACD 0.84 0.17
Stochastic Oscillator 90.83 25.86

Price Performance

Historical Comparison
NSP
ANIP

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: